NCT00014664View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

October 31, 2000

Conditions
Lymphoma
Interventions
BIOLOGICAL

apolizumab

Trial Locations (1)

94555

Protein Design Labs, Inc., Freemont

Sponsors
All Listed Sponsors
lead

PDL BioPharma, Inc.

INDUSTRY

NCT00014664 - Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter